Liver Biopsy in Primary Biliary Cholangitis: Indications and Interpretation

Area of Science:

• Hepatology
• Immunology
• Gastroenterology

Background:

• Primary biliary cholangitis (PBC) is an autoimmune liver disease.
• It is characterized by immune-mediated destruction of bile ducts, leading to cholestasis and fibrosis.
• PBC can progress to cirrhosis over several years.

Purpose of the Study:

• To review the diagnostic criteria for primary biliary cholangitis.
• To evaluate the role of liver biopsy in PBC diagnosis and staging.
• To discuss the implications of antimitochondrial antibody (AMA) status on diagnostic pathways.

Main Methods:

• Review of current diagnostic guidelines for PBC.
• Analysis of the utility of serologic autoantibody testing, specifically AMA.
• Assessment of the indications and prognostic value of liver biopsy in PBC.

Main Results:

• Diagnosis of PBC is typically established with clinical and serologic findings, particularly positive AMA.
• Liver biopsy is no longer mandatory for typical AMA-positive PBC cases.
• Biopsy remains crucial for AMA-negative patients and suspected autoimmune hepatitis overlap, enabling precise staging.

Conclusions:

• Diagnostic strategies for PBC have evolved, reducing reliance on liver biopsy in AMA-positive individuals.
• Liver biopsy retains essential diagnostic and prognostic value in specific PBC patient subgroups.
• Accurate staging through biopsy aids in prognosis assessment for patients with primary biliary cholangitis.